Applied DNA Sciences Announces Proposed Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- SK Hynix’s record plunge drags down global chip stocks
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- IBM misses Q2 targets as mainframe and software sales disappoint
- Goldman Sachs Upgrades NIO (NIO) to Buy
- Verizon planning new round of layoffs this week - Barron’s
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
Applied DNA Sciences (APDN) Prices $11.46M Offering of Stock and Warrants
March 27, 2015 9:05 AM EDTApplied DNA Sciences, Inc. (NASDAQ: APDN) announced that it has priced its previously announced underwritten public offering of 3,820,000 shares of its common stock and warrants to purchase up to an aggregate of 1,528,000shares of common stock, at a combined public offering price of $3.00. The warrants have an exercise price of $3.50 per share, expire on November 20, 2019 and will trade under the symbol APDNW.
The gross proceeds to the Company from this offering are estimated to be approximately $11.46 million before deducting the underwriting discount and other... More
Applied DNA Sciences (APDN) Plans Common, Warrants Offering
March 26, 2015 4:28 PM EDTApplied DNA Sciences (NASDAQ: APDN) announced that it intends to offer shares of common stock and warrants to purchase common stock in an underwritten public offering. Maxim Group LLC will serve as the sole book runner for the offering with The Benchmark Company... More
